Related Experiment Video
Updated: Aug 10, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy
H M Kantarjian1, F J Giles, S M O'Brien
1Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, USA.
Abstract:
This article begins with a review of the natural history of chronic myelogenous leukemia (CML), with an emphasis on prognostic features. Current standard therapy of CML with interferon-alpha based regimens, and interferon-alpha, in the context of allogenic stem cell transplantation is then discussed. Finally, some potentially effective novel agents including homoharringtonine, decitabine, ATRA, and topotecan are described.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cryptococcal Meningitis
Inhibitors of Viral Protein Synthesis

